Skip to main content

Table 1 Summary of interviews with health care providers

From: Feasibility and acceptability of injectable artesunate for the treatment of severe malaria in the Democratic Republic of Congo

Question/parameter Frequency Percentage [95 % CI]
Did you spend more or less time to prepare artesunate compared to quinine (N = 24)?
 More time 3 12.5 [2.7, 32.4]
 Same time 3 12.5 [2.7, 32.4]
 Less time 18 75 [53.3, 90.2]
Did you find more or less difficult to prepare artesunate compared to quinine (N = 24)?
 More difficult 3 12.5 [2.7, 32.4]
 Same difficulty 3 12.5 [2.7, 32.4]
 Less difficult 18 75 [53.3, 90.2]
Most cited reasons to support ease of use of injectable artesunate (N = 24)
 Rapid way of administration 15 62.5 [40.6, 81.2]
 No accidents related to infusion 11 45.8 [25.6, 67.2]
 Reduced patient’s monitoring time 5 20.8 [7.1, 42.2]
Time to observe effects of injectable artesunate compared to quinine (N = 31)?
 Less time 29 93.6 [78.6, 99.2]
 Same time 1 3.2 [0.1, 16.7]
 More time 1 3.2 [0.1, 16.7]
Have you noticed any adverse events that you think could be related to artesunate (N = 31)?
 Yes 7 22.6 [9.6, 41.1]
 No 24 77.4 [58.9, 90.4]
Which adverse events did you notice (N = 7)
 Decrease of haemoglobin level 5 71.4 [29.0, 96.3]
 Shivering after drug injection 3 42.9 [9.9, 81.6]
 Loss of weight 1 14.3 [0.4, 57.9]
If you noticed adverse events, would you say that: (N = 7)
 They are less than those observed with quinine 7 100
 They are the same than those observed with quinine 0 0
 They are more than those observed with quinine 0 0
 Don’t know 0 0
Do you think that the workload has reduced with artesunate compare to quinine (N = 31)?
 The workload has diminished 26 83.9 [66.3, 95.4]
 The workload is the same 4 12.9 [3.6, 29.8]
 The workload has increased 1 3.2 [0.1, 16.7]
What is your level of satisfaction with injectable artesunate (N = 31)?
 Very satisfied 19 61.3 [42.2, 78.2]
 Satisfied 12 38.7 [21.8, 57.8]
 Dissatisfied 0 0
Most important reasons for being very satisfied/satisfied with injectable artesunate N = 31)
 Lack of adverse events 17 54.8 [36.0, 72.7]
 Rapid action of the drug 15 48.3 [30.2, 66.9]
 Easy way to prepare and administer 9 29.0 [12.4, 48.0]
 Injectable artesunate more effective 9 29.0 [12.4, 48.0]
 Work load reduction 8 25.8 [11.9, 44.6]